DK0606391T3 - Inhibering af karforsnævring under anvendelse af anti-PADGEM-antistoffer - Google Patents
Inhibering af karforsnævring under anvendelse af anti-PADGEM-antistofferInfo
- Publication number
- DK0606391T3 DK0606391T3 DK92922039T DK92922039T DK0606391T3 DK 0606391 T3 DK0606391 T3 DK 0606391T3 DK 92922039 T DK92922039 T DK 92922039T DK 92922039 T DK92922039 T DK 92922039T DK 0606391 T3 DK0606391 T3 DK 0606391T3
- Authority
- DK
- Denmark
- Prior art keywords
- padgem
- inhibition
- vascular
- intravascular
- vascular narrowing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
- C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76883491A | 1991-09-30 | 1991-09-30 | |
PCT/US1992/008163 WO1993006863A1 (en) | 1991-09-30 | 1992-09-30 | Inhibition of vascular narrowing using anti-padgem antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0606391T3 true DK0606391T3 (da) | 1999-05-03 |
Family
ID=25083621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92922039T DK0606391T3 (da) | 1991-09-30 | 1992-09-30 | Inhibering af karforsnævring under anvendelse af anti-PADGEM-antistoffer |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0606391B1 (da) |
JP (1) | JPH07502726A (da) |
AT (1) | ATE169227T1 (da) |
AU (1) | AU678757B2 (da) |
CA (1) | CA2120240A1 (da) |
DE (1) | DE69226531T2 (da) |
DK (1) | DK0606391T3 (da) |
ES (1) | ES2123010T3 (da) |
WO (1) | WO1993006863A1 (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5770198A (en) * | 1988-05-18 | 1998-06-23 | The Research Foundation Of The State Of New York | Platelet-specific chimeric 7E3 immunoglobulin |
AU2305201A (en) * | 1993-11-05 | 2001-05-03 | Centocor Inc. | Platelet-specific chimeric immunoglobulin and methods of use therefor |
NZ527820A (en) * | 1993-11-05 | 2005-04-29 | Centocor Inc | Platelet-specific chimeric immunoglobulin and methods of use therefor |
AU6173501A (en) | 2000-05-19 | 2001-12-03 | Blood Res Center | Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
EP1714661A3 (en) * | 2000-05-19 | 2012-03-14 | The Center for Blood Research, INC. | Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
SG172616A1 (en) | 2004-04-13 | 2011-07-28 | Hoffmann La Roche | Anti-p-selectin antibodies |
HUE041957T2 (hu) | 2006-12-01 | 2019-06-28 | Novartis Ag | Anti-P-szelektin antitestek és eljárások azok alkalmazására gyulladásos betegségek kezelésére |
US20110212096A1 (en) | 2006-12-01 | 2011-09-01 | Scott Rollins | Anti-p-selectin antibodies and methods of their use and identification |
US8945565B2 (en) | 2006-12-01 | 2015-02-03 | Selexys Pharmaceuticals Corporation | Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies |
JP5524967B2 (ja) | 2008-09-19 | 2014-06-18 | エフ.ホフマン−ラ ロシュ アーゲー | 新規抗体処方物 |
US20200087403A1 (en) | 2017-03-15 | 2020-03-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Pharmaceutical compositions for the treatment of thrombosis in patients suffering from a myeloproliferative neoplasm |
WO2018234308A1 (en) | 2017-06-20 | 2018-12-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | METHODS FOR IDENTIFYING IF PATIENTS WITH ACUTE CARDIAC DISEASE FAILURE (ICAD) HAVE A HYPERCOAGULABLE CONDITION |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991001380A1 (fr) * | 1989-07-25 | 1991-02-07 | Institut National De La Sante Et De La Recherche Medicale | Anticorps monoclonaux diriges contre des proteines impliquees dans les fonctions plaquettaires, leur application en tant qu'agent diagnostique et therapeutique |
DK0496832T3 (da) * | 1989-10-20 | 1996-12-30 | New England Medical Center Inc | Inhibering af PADGEM-formidlet cellebinding |
WO1991007993A1 (en) * | 1989-11-30 | 1991-06-13 | Mathew Vadas | Anti-inflammatory and anti-adhesive factors |
-
1992
- 1992-09-30 ES ES92922039T patent/ES2123010T3/es not_active Expired - Lifetime
- 1992-09-30 AT AT92922039T patent/ATE169227T1/de not_active IP Right Cessation
- 1992-09-30 WO PCT/US1992/008163 patent/WO1993006863A1/en active IP Right Grant
- 1992-09-30 CA CA002120240A patent/CA2120240A1/en not_active Abandoned
- 1992-09-30 DE DE69226531T patent/DE69226531T2/de not_active Expired - Fee Related
- 1992-09-30 JP JP5506965A patent/JPH07502726A/ja not_active Ceased
- 1992-09-30 AU AU28694/92A patent/AU678757B2/en not_active Ceased
- 1992-09-30 DK DK92922039T patent/DK0606391T3/da active
- 1992-09-30 EP EP92922039A patent/EP0606391B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0606391A1 (en) | 1994-07-20 |
DE69226531D1 (de) | 1998-09-10 |
AU678757B2 (en) | 1997-06-12 |
EP0606391B1 (en) | 1998-08-05 |
ES2123010T3 (es) | 1999-01-01 |
ATE169227T1 (de) | 1998-08-15 |
CA2120240A1 (en) | 1993-03-31 |
AU2869492A (en) | 1993-05-03 |
DE69226531T2 (de) | 1999-05-06 |
JPH07502726A (ja) | 1995-03-23 |
WO1993006863A1 (en) | 1993-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0606391T3 (da) | Inhibering af karforsnævring under anvendelse af anti-PADGEM-antistoffer | |
HK1225741A1 (zh) | 用於治療和預防異種移植或急性血管排斥反應的補體c5激活的抑制 | |
DK1007089T3 (da) | Humaniserede antikoagulant-antistoffer mod Faktor IX til anvendelse i behandlingen af trombose | |
DE69418936T2 (de) | Gerät zur Dilatation einer Gefässstenose | |
NZ511956A (en) | Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies | |
DE69233482D1 (de) | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen | |
DE69220355D1 (de) | Selbstausspreizbare, vaskuläre Endoprothese | |
DK0603305T3 (da) | Anvendelse af et thymosin til behandling af hepatitis C | |
ITTO930940A1 (it) | Innesto protesico vascolare | |
FR2698537B1 (fr) | Prothèse tricompartimentale du genou. | |
ATE196849T1 (de) | Verfahren zur behandlung von multiplesklerose | |
DE489659T1 (de) | Verfahren zur behandlung von metallen mittels beschichtung sowie anlage zur durchfuehrung des verfahrens. | |
GB0031448D0 (en) | Inhibition of the vWF-collagen interaction by anti-human vWF monoclonal antibody (82D6A3) results in abolition of in vivo arterial platelet thrombus formation | |
DK0686044T3 (da) | Hæmning af intimal hyperplasi under anvendelse af antistoffer mod PDGF-receptorer | |
DE69232579T2 (de) | Anti-Plättchen-Wachstumsfaktor-Antikörper in der Behandlung von Restenose | |
ES2123597T3 (es) | Construcciones de anticuerpos que se unen a granulocitos, su preparacion y empleo. | |
Azrin et al. | Preparation, characterization, and evaluation of a monoclonal antibody against the rabbit platelet glycoprotein IIb/IIIa in an experimental angioplasty model. | |
WO1991007986A8 (en) | Method of treating septic shock | |
FR2697154B1 (fr) | Perfectionnement au composant fémoral des prothèse du genou. | |
ITMI910491A0 (it) | Immonotossina da anticorpi monoclonali anti-cds | |
DE59208707D1 (de) | Verfahren zur Reinigung von Streptolysin 0, intaktes Streptolysin 0 erhältlich nach diesem Verfahren und seine Verwendung | |
DK0610447T3 (da) | CDw52-specifikt antistof til behandling af T-cellemedieret inflammation af leddene | |
RU96112183A (ru) | Тромбоцит - специфичный химерный иммуноглобулин и методы его использования | |
DE69025629D1 (de) | Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids-verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern | |
ATE110786T1 (de) | Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa. |